Key Statistics for SRX
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (AUD) (ttm)
|Est. EPS (AUD) (06/2014)
|Est. PEG Ratio
|Market Cap (M AUD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (AUD)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SRX
- Net Income (M/AUD)
Sirtex Medical Limited is a medical company which researches, develops and commercializes medical products for the treatment of liver cancer. The Company is based in Western Australia and markets its products throughout the world. The Company's products include "SIR-Spheres," which uses micro-particle technology to treat liver cancer.
More Company Profile & Key Executives for SRX
|Gilman WongManaging Director/CEO||Darren SmithCFO/Secretary|
|David CadeChief Medical Officer||Michael ManganoPresident:US|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.